Base-case model results using DURATION-6 trial clinical inputs.
收藏数据链接：
官方服务：
资源简介：
HbA1c = glycated hemoglobin; ICER = incremental cost-effectiveness ratio; QD = once daily; QW = once weeklyThe liraglutide incremental cost-effectiveness ratio (ICER) indicates that strategy is expected to cost $4,773 for a 1% reduction in HbA1c relative to the exenatide strategy.Base-case model results using DURATION-6 trial clinical inputs.
创建时间：
2015-12-03
